Physician profile
John Wharton
NPI 1386752327
$43,632.98
in general payments reported to CMS, 2019-2025
10 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $13K · 2021: $15.78 · 2022: $11K · 2023: $4.55 · 2024: $227 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $37,814.55 | 2019-2022 | |
| Janssen Global Services, LLC | $4,640.00 | 2022 | |
| Medtronic Vascular, INC. | $323.22 | 2019-2020 | |
| Medtronic, INC. | $244.68 | 2024-2025 | Aurora Ev-Icd Mri Surescan, Sphere-9, Linq II |
| Biosense Webster, INC. | $203.19 | 2019-2021 | |
| Boston Scientific Corporation | $161.64 | 2024 | |
| Biosig Technologies, INC. | $130.73 | 2019 | |
| Abbott Laboratories | $95.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.43 | 2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4.55 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wharton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.